Prophylactic use of the IL-2 receptor-specific monoclonal antibody LO-Tact-1 with cyclosporin A and steroids in renal transplantation.

[1]  P. Familletti,et al.  Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys. , 1991, Journal of immunology.

[2]  T. Waldmann,et al.  A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. , 1991, Transplantation.

[3]  R. Fisher,et al.  Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.

[4]  M. Giral,et al.  Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. , 1990, The New England journal of medicine.

[5]  M. Giral,et al.  ANTI‐INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN THE TREATMENT OF ONGOING ACUTE REJECTION EPISODES OF HUMAN KIDNEY GRAFT‐A PILOT STUDY , 1989, Transplantation.

[6]  T. Strom,et al.  PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL IN MURINE RECIPIENTS TREATED WITH A DIPHTHERIA TOXIN RELATED INTERLEUKIN‐2 FUSION PROTEIN , 1989, Transplantation.

[7]  M. Dallman,et al.  Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal antibody therapy. , 1988, Transplantation proceedings.

[8]  L. Chatenoud,et al.  One-month prophylactic use of OKT3 in cadaver kidney transplant recipients. , 1988 .

[9]  P. Rieu,et al.  Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone. , 1987, Transplantation Proceedings.

[10]  D. Olive,et al.  PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2 , 1987, The Lancet.

[11]  T. Strom,et al.  Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice , 1985 .

[12]  H. Bazin,et al.  Rat monoclonal antibodies. II. A rapid and efficient method of purification from ascitic fluid or serum. , 1984, Journal of immunological methods.